40.86 USD
↗ 1.48 (3.76%)AT CLOSE (03:59 PM EST)
Hemab Therapeutics Holdings, Inc. Common Stock
COAGNASDAQ • USD
40.88
↗ 0.02 (0.04%)
POST MARKET (AS OF 04:14 PM EST)
Post Market
AS OF 04:14 PM EST
40.88
↗ 0.02 (0.04%)
Market: CLOSED
Hemab Therapeutics Holdings, Inc. Common Stock (COAG) trades at $40.86 per share. Technical indicators currently signal "Buy". Key drivers include negative Return on Equity and a bullish Golden Cross on the moving averages. COAG is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Nov 13, 2026.
Open?$39.37
High?$41.27
Low?$38.44
Prev. Close?$39.38
Volume?401.1K
Avg. Volume?479.1K
VWAP?$40.34
Rel. Volume?0.84x
Bid / Ask
Bid?$16.18 × 200
Ask?$47.83 × 100
Spread?$31.65
Midpoint?$32.00
Valuation & Ratios
Market Cap?1.9B
Shares Out?N/A
Float?23.1M
Float %?49.6%
P/E Ratio?N/A
P/B Ratio?4.45
EPS?-$1.59
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Hemab Therapeutics Holdings Inc is a clinical-stage biotechnology company developing therapies for the treatment of blood coagulation disorders. It focuses on discovering, developing, and commercializing treatments for conditions such as Glanzmann thrombasthenia, Factor VII deficiency, and von Willebrand disease. Its flagship candidate, sutacimig (HMB-001), is a bispecific antibody currently in clinical trials for the prophylactic treatment of Glanzmann thrombasthenia and Factor VII deficiency. The company has one operating segment, engaged in the research and development of prophylactic therapeutics for bleeding disorders.
Employees
N/A
Market Cap
1.9B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2026-05-01
Address
101 MAIN STREET
CAMBRIDGE, MA 02142
Phone: 45 2138 7627
CAMBRIDGE, MA 02142
Phone: 45 2138 7627
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestHigh
Short % of Float?14.28%High
Short Interest?3.3M
Days to Cover?7.3
Free Float23.1M
Avg Daily Volume452.0K
Settlement Date2026-10-30
Financial Health
Current Ratio?33.86Strong
Quick Ratio?33.86Strong
Cash Ratio?18.48Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?4.45FAIR▾
Peers100
S&P40
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-21.0CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-17.3%WEAK▾
S&P8
ROA?-16.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-89076000
Enterprise Value?$1.7B
Fundamentals ratios updated end of day